Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jon Willie

Neurological Surgery Austin, TX Medical Doctor

NPI 1194934034 CMS profile 53809

1601 Trinity St, Austin, TX 78712

Open in the dashboard

General payments

$137,331

230 records reported · program years 2019–2025

Research payments

$63,619

Paid to them · 100 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$279,266 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Jon Willie of Austin, TX is reported in the CMS Open Payments database as having received $137,331 across 230 general payments and $63,619 in research payments paid to them. Separately, studies naming them as principal investigator received $279,266 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $33,569 65
2025 Research $29,774 54
2024 General $5,674 13
2024 Research $10,298 30
2023 General $13,967 19
2023 Research $23,546 16
2022 General $25,017 46
2021 General $9,144 5
2020 General $29,834 37
2019 General $20,126 45

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jon Willie
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Jon Willie were reported at $33,569. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Jon Willie Neurological Surgery median Middle half National median
2019 $20,126 $582 $138–$3,006 $163
2020 $29,834 $294 $76–$2,174 $114
2021 $9,144 $387 $105–$2,432 $132
2022 $25,017 $542 $139–$2,989 $149
2023 $13,967 $534 $145–$2,697 $160
2024 $5,674 $574 $155–$3,046 $164
2025 $33,569 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $70,237 105 payments
  2. Medtronic USA, Inc. $45,050 62 payments
  3. ClearPoint Neuro, Inc. $12,730 18 payments
  4. NeuroPace, Inc. $4,399 10 payments
  5. Abbott Laboratories $1,309 15 payments
  6. DIXI Medical USA Corp $729 1 payment
  7. F. Hoffmann-La Roche AG $725 1 payment
  8. Zimmer Biomet Holdings, Inc. $565 3 payments
  9. Boston Scientific Corporation $539 5 payments
  10. InSightec,Inc $361 4 payments
  11. Other $687 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $82,965 18 payments
  2. Consulting Fee $23,946 8 payments
  3. Travel and Lodging $18,882 66 payments
  4. Food and Beverage $11,520 137 payments
  5. Grant $19 1 payment
Products named General payments · program years 2019–2025
  1. VISUALASE MRI-guided laser ablation $35,757 47 payments
  2. VISUALASE MRI-guided laser ablation $28,323 46 payments
  3. StealthStation $16,412 13 payments
  4. CLEARPOINT $12,730 18 payments
  5. STEALTHSTATION S8 PLATFORM $9,299 14 payments
  6. INTELLIS ADAPTIVESTIM $8,005 12 payments
  7. RNS System $3,940 6 payments
  8. PERCEPT PC BRAINSENSE $2,804 6 payments
  9. SenSight $803 4 payments
  10. INFINITY $526 3 payments
  11. Other $3,735 40 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. NeuroPace, Inc. $63,619 100 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

80

Median for Neurosurgery: 83

Drug cost

$542

Median for Neurosurgery: $872

Branded share of claims

0%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Mupirocin Generic 80 $542

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$102,804

Medicare's payments for the services billed

Medicare patients

108

Average age 69

Services billed

234

47 women, 61 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 55%
Depression 44%
Diabetes 31%
Ischemic heart disease 28%
Chronic kidney disease 23%
Cancer 23%
Alzheimer's or dementia 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

330 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record